OBJECTIVE: To assess the factors that contributed to the successful completion of recruitment for the largest clinical trial ever conducted in Australia, the Aspirin in Reducing Events in the Elderly (ASPREE) study. DESIGN: Enrolment of GPs; identification of potential participants in general practice databases; screening of participants. SETTING, PARTICIPANTS: Selected general practices across southeast Australia (Tasmania, Victoria, Australian Capital Territory, New South Wales, South Australia). MAJOR OUTCOMES: Numbers of patients per GP screened and randomised to participation; geographic and demographic factors that influenced screening and randomising of patients. RESULTS:2717 of 5833 GPs approached (47%) enrolled to recruit patients for the study; 2053 (76%) recruited at least one randomised participant. The highest randomised participant rate per GP was for Tasmania (median, 5; IQR, 1-11), driven by the high rate of participant inclusion at phone screening. GPs in inner regional (adjusted odds ratio [aOR], 1.45; 95% CI, 1.14-1.84) and outer regional areas (aOR, 1.86; 95% CI, 1.19-2.88) were more likely than GPs in major cities to recruit at least one randomised participant. GPs in areas with a high proportion of people aged 70 years or more were more likely to randomise at least one participant (per percentage point increase: aOR, 1.10; 95% CI, 1.05-1.15). The number of randomised patients declined with time from GP enrolment to first randomisation. CONCLUSION: General practice can be a rich environment for research when barriers to recruitment are overcome. Including regional GPs and focusing efforts in areas with the highest proportions of potentially eligible participants improves recruitment. The success of ASPREE attests to the clinical importance of its research question for Australian GPs.
RCT Entities:
OBJECTIVE: To assess the factors that contributed to the successful completion of recruitment for the largest clinical trial ever conducted in Australia, the Aspirin in Reducing Events in the Elderly (ASPREE) study. DESIGN: Enrolment of GPs; identification of potential participants in general practice databases; screening of participants. SETTING, PARTICIPANTS: Selected general practices across southeast Australia (Tasmania, Victoria, Australian Capital Territory, New South Wales, South Australia). MAJOR OUTCOMES: Numbers of patients per GP screened and randomised to participation; geographic and demographic factors that influenced screening and randomising of patients. RESULTS: 2717 of 5833 GPs approached (47%) enrolled to recruit patients for the study; 2053 (76%) recruited at least one randomised participant. The highest randomised participant rate per GP was for Tasmania (median, 5; IQR, 1-11), driven by the high rate of participant inclusion at phone screening. GPs in inner regional (adjusted odds ratio [aOR], 1.45; 95% CI, 1.14-1.84) and outer regional areas (aOR, 1.86; 95% CI, 1.19-2.88) were more likely than GPs in major cities to recruit at least one randomised participant. GPs in areas with a high proportion of people aged 70 years or more were more likely to randomise at least one participant (per percentage point increase: aOR, 1.10; 95% CI, 1.05-1.15). The number of randomised patients declined with time from GP enrolment to first randomisation. CONCLUSION: General practice can be a rich environment for research when barriers to recruitment are overcome. Including regional GPs and focusing efforts in areas with the highest proportions of potentially eligible participants improves recruitment. The success of ASPREE attests to the clinical importance of its research question for Australian GPs.
Authors: C M Reid; P Ryan; M Nelson; P Beckinsale; M McMurchie; D Gleave; F DeLoozef; L M Wing Journal: Clin Exp Pharmacol Physiol Date: 2001-08 Impact factor: 2.557
Authors: Christopher M Williams; Christopher G Maher; Mark J Hancock; James H McAuley; Chung-Wei Christine Lin; Jane Latimer Journal: J Clin Epidemiol Date: 2013-10-31 Impact factor: 6.437
Authors: A E Borgiel; E V Dunn; C T Lamont; P J MacDonald; M K Evensen; M J Bass; R A Spasoff; J I Williams Journal: Fam Pract Date: 1989-09 Impact factor: 2.267
Authors: Lindon M H Wing; Christopher M Reid; Philip Ryan; Lawrence J Beilin; Mark A Brown; Garry L R Jennings; Colin I Johnston; John J McNeil; Graham J Macdonald; John E Marley; Trefor O Morgan; Malcolm J West Journal: N Engl J Med Date: 2003-02-13 Impact factor: 91.245
Authors: Christine L Paul; Leon Piterman; Jonathan E Shaw; Catherine Kirby; Kristy L Forshaw; Jennifer Robinson; Isaraporn Thepwongsa; Robert W Sanson-Fisher Journal: Trials Date: 2017-03-23 Impact factor: 2.279
Authors: Jessica E Lockery; Jonathan C Broder; Joanne Ryan; Ashley C Stewart; Robyn L Woods; Trevor T-J Chong; Geoffrey C Cloud; Anne Murray; Jason D Rigby; Raj Shah; Elsdon Storey; Stephanie A Ward; Rory Wolfe; Christopher M Reid; Taya A Collyer; Michael E Ernst Journal: J Gen Intern Med Date: 2021-03-22 Impact factor: 6.473
Authors: Jessica E Lockery; Taya A Collyer; Christopher M Reid; Michael E Ernst; David Gilbertson; Nino Hay; Brenda Kirpach; John J McNeil; Mark R Nelson; Suzanne G Orchard; Kunnapoj Pruksawongsin; Raj C Shah; Rory Wolfe; Robyn L Woods Journal: Trials Date: 2019-12-09 Impact factor: 2.279
Authors: Paul Lacaze; Robert Sebra; Moeen Riaz; Jane Tiller; Jerico Revote; James Phung; Emily J Parker; Suzanne G Orchard; Jessica E Lockery; Rory Wolfe; Maya Strahl; Ying C Wang; Rong Chen; Daniel Sisco; Todd Arnold; Bryony A Thompson; Daniel D Buchanan; Finlay A Macrae; Paul A James; Walter P Abhayaratna; Trevor J Lockett; Peter Gibbs; Andrew M Tonkin; Mark R Nelson; Christopher M Reid; Robyn L Woods; Anne M Murray; Ingrid Winship; John J McNeil; Eric Schadt Journal: Genet Med Date: 2020-07-01 Impact factor: 8.822
Authors: Suzanne E Mahady; Karen L Margolis; Andrew Chan; Galina Polekhina; Robyn L Woods; Rory Wolfe; Mark R Nelson; Jessica E Lockery; Erica M Wood; Christopher Reid; Michael E Ernst; Anne Murray; Ltp Thao; John J McNeil Journal: Gut Date: 2020-08-03 Impact factor: 31.793
Authors: Liubov D Robman; Le Thi Phuong Thao; Robyn H Guymer; Rory Wolfe; Robyn L Woods; Lauren Ab Hodgson; James Phung; Galina A Makeyeva; Y-Anh Le-Pham; Suzanne G Orchard; Jewhara Suleiman; Emily Maguire; Ruth E Trevaks; Stephanie A Ward; Moeen Riaz; Paul Lacaze; Elsdon Storey; Walter P Abhayaratna; Mark R Nelson; Michael E Ernst; Christopher M Reid; John J McNeil Journal: Contemp Clin Trials Commun Date: 2020-10-11
Authors: Joanne Ryan; Robyn L Woods; Carlene J Britt; Anne M Murray; Raj C Shah; Christopher M Reid; Rory Wolfe; Mark R Nelson; Suzanne G Orchard; Jessica E Lockery; Ruth E Trevaks; Elsdon Storey Journal: J Alzheimers Dis Rep Date: 2020-08-04
Authors: Tú Nguyen-Dumont; James G Dowty; Robert J MacInnis; Jason A Steen; Moeen Riaz; Pierre-Antoine Dugué; Anne-Laure Renault; Fleur Hammet; Maryam Mahmoodi; Derrick Theys; Helen Tsimiklis; Gianluca Severi; Damien Bolton; Paul Lacaze; Robert Sebra; Eric Schadt; John McNeil; Graham G Giles; Roger L Milne; Melissa C Southey Journal: Cancers (Basel) Date: 2021-03-24 Impact factor: 6.639
Authors: Joanne Ryan; Elsdon Storey; Anne M Murray; Robyn L Woods; Rory Wolfe; Christopher M Reid; Mark R Nelson; Trevor T J Chong; Jeff D Williamson; Stephanie A Ward; Jessica E Lockery; Suzanne G Orchard; Ruth Trevaks; Brenda Kirpach; Anne B Newman; Michael E Ernst; John J McNeil; Raj C Shah Journal: Neurology Date: 2020-03-25 Impact factor: 11.800
Authors: Ingrid Winship; Eric Schadt; John J McNeil; Paul Lacaze; Robert Sebra; Moeen Riaz; Jodie Ingles; Jane Tiller; Bryony A Thompson; Paul A James; Diane Fatkin; Christopher Semsarian; Christopher M Reid; Andrew M Tonkin Journal: NPJ Genom Med Date: 2021-06-16 Impact factor: 8.617